Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Kissei Pharmaceutical's Vasculitis Drug: The Paper that Formed the Basis for Its Approval Has Been Retracted - US Medical Journal: Asahi Shimbun

Summary by Asahi
A US medical journal has retracted the clinical research paper that formed the basis for the approval of the vasculitis treatment drug "Tabneos" (generic name avacopan). In Japan, it is sold by Kissei Pharmaceutical Co., Ltd. (Matsumoto City, Nagano Prefecture), and the study involved patient deaths after taking the drug…

1 Articles

AsahiAsahi
Lean Left

Kissei Pharmaceutical's Vasculitis Drug: The Paper that Formed the Basis for Its Approval Has Been Retracted - US Medical Journal: Asahi Shimbun

A US medical journal has retracted the clinical research paper that formed the basis for the approval of the vasculitis treatment drug "Tabneos" (generic name avacopan). In Japan, it is sold by Kissei Pharmaceutical Co., Ltd. (Matsumoto City, Nagano Prefecture), and the study involved patient deaths after taking the drug…

·Tokyo, Japan
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Asahi broke the news in Tokyo, Japan on Friday, July 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Nagano Prefecture icon

Nagano Prefecture

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal